AUD 0.07
(0.0%)
Year | Net Income | Net Income Growth |
---|---|---|
2023 | -5.06 Million AUD | 11.19% |
2022 | -5.85 Million USD | -150.81% |
2021 | -2.33 Million AUD | 74.74% |
2020 | -9.23 Million AUD | 26.77% |
2019 | -12.61 Million AUD | 24.61% |
2018 | -16.73 Million AUD | 1.45% |
2017 | -16.98 Million AUD | -51.98% |
2016 | -11.17 Million AUD | 0.0% |
Year | Net Income | Net Income Growth |
---|---|---|
2023 Q2 | -1.34 Million USD | -0.37% |
2023 Q3 | -1.28 Million USD | 4.41% |
2023 FY | -5.19 Million AUD | 11.19% |
2023 Q4 | -1.21 Million USD | 5.68% |
2023 Q1 | -1.34 Million USD | 32.3% |
2022 Q3 | -2.11 Million USD | 7.59% |
2022 Q4 | -1.98 Million USD | 6.05% |
2022 FY | -5.85 Million USD | -150.81% |
2022 Q2 | -2.28 Million USD | 0.0% |
2021 FY | -2.33 Million AUD | 74.74% |
2020 FY | -9.23 Million AUD | 26.77% |
2019 Q2 | -4.5 Million AUD | 0.0% |
2019 Q1 | -4.5 Million AUD | 0.0% |
2019 FY | -12.61 Million AUD | 24.61% |
2018 Q1 | -5.86 Million AUD | 0.0% |
2018 FY | -16.73 Million AUD | 1.45% |
2018 Q4 | -4.5 Million AUD | 0.0% |
2018 Q2 | -5.86 Million AUD | 0.0% |
2017 Q1 | -6.36 Million AUD | 0.0% |
2017 Q2 | -6.36 Million AUD | 0.0% |
2017 Q4 | - AUD | 0.0% |
2017 FY | -16.98 Million AUD | -51.98% |
2016 Q2 | - AUD | 0.0% |
2016 Q1 | - AUD | 0.0% |
2016 Q4 | -6.36 Million AUD | 0.0% |
2016 FY | -11.17 Million AUD | 0.0% |
2015 Q4 | - AUD | 0.0% |
Name | Net Income | Net Income Difference |
---|---|---|
4DMedical Limited | -35.97 Million AUD | 85.927% |
Adherium Limited | -10.22 Million AUD | 50.477% |
Aroa Biosurgery Limited | -9.74 Million AUD | 48.059% |
Atomo Diagnostics Limited | -6.84 Million AUD | 26.059% |
Anteris Technologies Ltd | -67.33 Million AUD | 92.48% |
Control Bionics Limited | -5.91 Million AUD | 14.381% |
CardieX Limited | -6.76 Million AUD | 25.158% |
Compumedics Limited | -338 Thousand AUD | -1398.02% |
Cochlear Limited | 356.8 Million AUD | 101.419% |
CleanSpace Holdings Limited | -3.12 Million AUD | -61.915% |
Cyclopharm Limited | -4.7 Million AUD | -7.711% |
EMVision Medical Devices Ltd | -2.72 Million AUD | -85.496% |
Nova Eye Medical Limited | -8.79 Million AUD | 42.397% |
HeraMED Limited | -6.78 Million AUD | 25.36% |
Imricor Medical Systems, Inc. | -22.62 Million AUD | 77.622% |
ImpediMed Limited | -19.79 Million AUD | 74.415% |
InhaleRx Limited | -1.44 Million AUD | -250.822% |
LBT Innovations Limited | -3.74 Million AUD | -35.383% |
Micro-X Limited | -9.76 Million AUD | 48.148% |
Neurotech International Limited | -5.06 Million AUD | 0.117% |
OncoSil Medical Limited | -11.91 Million AUD | 57.5% |
PolyNovo Limited | 5.26 Million AUD | 196.242% |
Respiri Limited | -7.12 Million AUD | 28.978% |
SomnoMed Limited | -12.24 Million AUD | 58.639% |
Universal Biosensors, Inc. | -6.74 Million AUD | 24.894% |
Uscom Limited | -2.07 Million AUD | -144.044% |